Terrie Curran
Director · Arcutis Biotherapeutics, Inc.
IndividualSelling only
- 2024
- Aug 28, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Terrie Curran files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd Watanabe - $4.44M in ARQT purchases and sales in the last 12 months
- Masaru Matsuda - $2.21M in ARQT purchases and sales in the last 12 months
- Howard G. Welgus - $1.95M in ARQT purchases and sales in the last 12 months
- Patrick Burnett - $1.56M in ARQT purchases and sales in the last 12 months
- Keith R. Leonard - $997K in ARQT purchases and sales in the last 12 months
- Neha Krishnamohan - $939K in ARQT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Terrie Curran?
Terrie Curran is a corporate insider, tracked as Director of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Terrie Curran submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Terrie Curran been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.08M) across all tracked filings.
